Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Addyi is now approved for the treatment of women younger than 65 years of age with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a coexisting medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance
01 Consult Begin with a concierge consultation, in-person or virtual
It is a theoretical concern based on mechanism, not an observed outcome
By linking these logged symptoms with the apps Estimated Medication Level chart, you can better anticipate and plan for days when side effects might be less intense
)
